Skip to main content

Home > Releases > Quarterly Financial Report > Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Total Current Liabilities

Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Total Current Liabilities (QFRTCL385USNO)

Q2 2026: 438,682
Updated: Sep 8, 2026 9:14 AM CDT
Q2 2026:  438,682  
Q1 2026:  424,249  
Q4 2025:  431,433  
Q3 2025:  417,248  
Q2 2025:  414,940  

Units:

Millions of Dollars,
Not Seasonally Adjusted

Frequency:

Quarterly

Fullscreen

Notes

Title Release Dates

2017-09-06 2026-09-08
 
Source    

2017-09-06 2026-09-08
 
Release    

2017-09-06 2026-09-08
 
Units    

2017-09-06 2026-09-08
 
Frequency    

2017-09-06 2026-09-08
 
Seasonal Adjustment    

2017-09-06 2026-09-08
 
Notes    

2017-09-06 2026-09-08